Invenra Inc

About

Invenra Inc is a specialized pharmaceutical company based in Madison, Wisconsin, dedicated to advancing bispecific antibody discovery and development. The company operates through its proprietary B-Body Bispecific Platform, an innovative antibody engineering technology designed to create high-yield, discovery-optimized, and CMC-ready therapeutic antibodies. Invenra focuses on developing bispecific and trispecific antibody technologies that offer superior therapeutic potential with subcutaneous compatibility, addressing critical needs in modern pharmaceutical development. The company positions itself with the mission of delivering "Better Bispecific Antibodies by Design," emphasizing their commitment to precision engineering and optimized therapeutic outcomes. Invenra offers flexible partnership opportunities for bispecific antibody research, enabling pharmaceutical companies and research institutions to leverage their advanced platform technology. Their Madison facility serves as the hub for cutting-edge antibody engineering, where specialized teams work on therapeutic bispecific antibody discovery and development projects. With their focus on next-generation antibody therapeutics, Invenra Inc represents a key player in the evolving landscape of precision medicine and targeted therapy development, providing essential capabilities for advancing complex antibody-based treatments from discovery through clinical development.